Senti Biosciences Inc. (SNTI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Senti Biosciences Inc. (SNTI:NASDAQ), powered by AI.

Current Price
$0.90
P/E Ratio
-0.1
Market Cap
4M
Sector
Healthcare
What is the Senti Biosciences Inc. stock price forecast?

Senti Biosciences Inc. is currently trading at $0.90. View real-time AI analysis on Alpha Lenz.

What is Senti Biosciences Inc. insider trading activity?

View the latest insider trading data for Senti Biosciences Inc. on Alpha Lenz.

What is Senti Biosciences Inc.'s P/E ratio?

Senti Biosciences Inc.'s P/E ratio is -0.1.

Senti Biosciences Inc.

NASDAQ · SNTI
$0.90
Ask about Senti Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Senti Biosciences Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -114.1%.

Ask for details

Company Overview

Senti Biosciences Inc. is a pioneering biotechnology company focused on the development of next-generation cell and gene therapies. Leveraging synthetic biology, the company engineers novel therapies aimed at treating a range of complex diseases, particularly those within oncology. Senti Biosciences is dedicated to advancing medicines that have the potential to fundamentally change treatment paradigms by enhancing efficacy, safety, and precision. The company's approach involves designing and optimizing genetic circuits that embody sophisticated decision-making paths, allowing therapies to efficiently target and modify disease cells. Its innovative technology platform underscores a commitment to unlocking new therapeutic possibilities and improving patient outcomes. Senti Biosciences plays a crucial role in the biomedical sector by accelerating the development of customizable and intelligent therapeutics, thus contributing to the dynamic and transformative landscape of healthcare solutions.

CEODr. Timothy K. Lu M.D., Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees34

Company Statistics

FY 2024

Profile

$4.14MMarket Cap
$0.00Revenue
0.00Shares Out
34Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.08P/E
0.16P/B
N/AEV/Sales
0.25EV/EBITDA
-0.10P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-48.58%ROA
-114.06%ROE
-55.88%ROIC

Financial Health

$48.28MCash & Cash Equivalents
$23.91MNet Debt
281.46%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Senti Biosciences Inc. (ticker: SNTI) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 34 employees. Market cap is $4M.

The current price is $0.901 with a P/E ratio of -0.08x and P/B of 0.16x.

ROE is -114.06%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Senti Biosciences Inc. (Healthcare) Stock Forecast & Analysis $0.90 | Alpha Lenz